ClinicalTrials.Veeva
Menu

Find clinical trials for Melanoma in Boston, MA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Cancer
Non-Small-Cell Lung Carcinoma
Squamous Cell Carcinoma of Head and Neck
Renal Cell Carcinoma
Neoplasm Metastasis
Carcinoma
Lung Cancer

Melanoma trials near Boston, MA, USA:

A Phase I/II Study of DYP688 in Patients With Metastatic Uveal Melanoma and Other GNAQ/11 Mutant Melanomas

of DYP688 as a single agent in patients with metastatic uveal melanoma (MUM) and other melanomas harboring GNAQ/11 mutations....

Active, not recruiting
Metastatic Uveal Melanoma
Drug: DYP688

Phase 1, Phase 2

Novartis
Novartis

Boston, Massachusetts, United States and 10 other locations

CDX-301 and Nivolumab or Pembrolizumab as a possible treatment for melanoma.The names of the study drugs involved in this study are:* Person...

Enrolling
Melanoma
Metastatic Melanoma
Drug: Nivolumab
Biological: NEOVAX

Phase 1

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Boston, Massachusetts, United States

This research study involves studying a device as a possible treatment for metastatic melanoma in the brain. The purpose of this study is to...

Not yet enrolling
Melanoma Brain Metastasis
Metastatic Melanoma
Drug: Pembrolizumab
Device: NovoTTF-200A

Phase 1, Phase 2

Brown University
Brown University

Providence, Rhode Island, United States

This research study is studying a targeted therapy called BVD-523 as a possible treatment for advanced uveal melanoma....

Active, not recruiting
Uveal Melanoma
Drug: BVD-523

Phase 2

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Boston, Massachusetts, United States and 1 other location

This is a Phase 3, randomized, multi-center, open-label study of neoadjuvant darovasertib in subjects with primary non-metastatic uveal melanoma...

Enrolling
Uveal Melanoma
Procedure: Primary Local Therapy
Drug: Darovasertib

Phase 3

Ideaya Biosciences

Boston, Massachusetts, United States and 74 other locations

Locations recently updated

This research study is studying a combination of drugs as a possible treatment for unresectable or metastatic melanoma.The drugs involved in...

Active, not recruiting
Metastatic Melanoma
Drug: Dabrafenib
Drug: Pembrolizumab

Phase 2

Mass General Brigham
Mass General Brigham

Boston, Massachusetts, United States and 2 other locations

The goal of this clinical trial is to understand if a new drug called LNS8801 can safely treat patients with melanoma. The primary question ...

Enrolling
Melanoma Stage IIIB-IV
Melanoma (Skin Cancer)
Biological: Immunotherapy (ipilimumab and nivolumab)
Biological: Immunotherapy (Pembrolizumab)

Phase 2, Phase 3

Linnaeus Therapeutics

Boston, Massachusetts, United States and 6 other locations

binimetinib, and pembrolizumab) given together for the treatment of melanoma that:* is advanced or metastatic (spread to other parts of the ...

Active, not recruiting
Melanoma
Drug: Binimetinib
Drug: Encorafenib

Phase 3

Pfizer
Pfizer

Boston, Massachusetts, United States and 132 other locations

therapy per local standard of care \[SoC\], best supportive care \[BSC\] on protocol survivor follow up) in patients with advanced non-ocular melanoma...

Enrolling
Advanced Melanoma
Drug: Tebentafusp with Pembrolizumab
Drug: Tebentafusp

Phase 3

Immunocore
Immunocore

Boston, Massachusetts, United States and 71 other locations

and overall survival (OS) for patients with NRAS-mutant (NRASm) melanoma who are randomized to receive the combination of naporafenib + tram...

Enrolling
Advanced or Metastatic NRAS-mutant Melanoma
Drug: Trametinib
Drug: Naporafenib

Phase 3

Erasca

Boston, Massachusetts, United States and 58 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems